$DTIL Cashflow Statement | Understand Stock

$DTIL

$6.79 +$0.38 (5.93%) Close

$DTIL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization
Share-based compensation
Impairment charges
(Gain) loss on disposal of assets
Issuance of common stock in exchange for services
Non-cash interest expense
Amortization of right-of-use assets
Non-cash consideration received from collaboration partners
Loss (gain) on changes in other fair value adjustments
Gain on deconsolidation of subsidiary
Loss from equity method investment
Gain from disposal of business
Amortization of discount on note receivable
Gain on change in fair value of warrant liability
Changes in operating assets and liabilities:
Prepaid expenses
Marketable securities
Convertible note receivable
Accounts receivable
Contract asset
Other assets and other current assets
Accounts payable
Other liabilities and other current liabilities
Deferred revenue
Lease liabilities and right-of-use assets
Lease liabilities
Contract liabilities
Net cash used in operating activities

Cash flows from investing activities:
Proceeds from disposal of business
Purchases of property, equipment and software
Purchases of intangibles assets
Proceeds from sale of equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from stock option exercises
Proceeds from employee stock purchase plan
Proceeds from offering of common stock, net of issuance costs
Proceeds from offering of common stock and warrants, net of issuance costs
Proceeds from offering of common stock and warrants through underwritten offering, net of issuance costs
Proceeds from issuance of common stock through ATM facility, net of issuance cost
Proceeds from offering of common stock to collaboration partners and licensees
Repayment of revolving credit facility
Borrowings from term loan debt facility, net of issuance costs paid to lender
Payments of debt issuance costs
Payment of term loan
Borrowings from revolving credit facility
Borrowings from revolving credit facility, net of issuance costs paid to lender
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents, and restricted cash—beginning of period
Cash, cash equivalents, and restricted cash —end of period
Supplemental disclosures of noncash financing and investing activities:
Property, equipment and software additions included in accounts payable, accrued expenses and other current liabilities
Intangible asset additions included in accounts payable and accrued expenses and other current liabilities
Cash paid for interest
Unsettled at-the-market issuances of common stock included in other current assets
Contract liability accrual related to Servier Program Purchase Agreement milestones
Non-cash consideration received from collaboration partners

Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments